Express News | Ruifeng Hi-Tech: Directors and executives plan to reduce their holdings by no more than 0.1597%

BreakingsMay 23 05:22

Synthetic biology concept stocks opened and fell, and Xinghu Technology hit a fall. Lukang Pharmaceutical, Shuangta Foods, and Weilan Biotech fell by more than 5%, while Fujilai, Hualu Biotech, Yiduoli, and Ruifeng High Materials followed suit.

Synthetic biology concept stocks opened and fell, and Xinghu Technology hit a fall. Lukang Pharmaceutical, Shuangta Foods, and Weilan Biotech fell by more than 5%, while Fujilai, Hualu Biotech, Yiduoli, and Ruifeng High Materials followed suit.

Zhitong FinanceMay 16 20:43

Ruifeng High Materials (300243.SZ): The new energy battery binder business is in the early stages of business development and marketing

Gelonghui, May 13 | Ruifeng High Materials (300243.SZ) said on the investor interactive platform that the new energy battery binder business is in the early stages of business development and marketing, and has not established a supply relationship with it until now.

Gelonghui FinanceMay 13 04:52

Ruifeng Hi-Tech: No downward revision of the “Ruifeng Convertible Bonds” conversion price

Shandong Ruifeng Polymer Materials Co., Ltd. announced that the company held the 18th meeting of the 5th board of directors on May 10, 2024 to review and pass the “Proposal on Not to Lower Revise the “Ruifeng Convertible Bonds” conversion price. The board of directors of the company decided not to revise the “Ruifeng Bonds” conversion price downward this time, and within the next six months (that is, May 11, 2024 to November 10, 2024), if it triggers the “Ruifeng Bonds” conversion price downward once again, and does not propose a downward revision plan.

Zhitong FinanceMay 10 04:57

Express News | Ruifeng High Materials: Sales revenue of black phosphorus products is expected to not exceed 500,000 yuan this year, and sales revenue of synthetic biomaterial-related products will not exceed 1 million yuan

BreakingsMay 8 07:44

Ruifeng Hi-Tech: Currently, the subsidiary Ruifeng Biotech has no plans to invest in large-scale production lines for products related to synthetic biomaterials

Gelonghui, May 8 | Ruifeng High Materials announced that in March 2023, the company invested in the establishment of a wholly-owned subsidiary, Shandong Ruifeng Biomaterials Co., Ltd., to lay out the synthetic biomaterials industry. At present, Ruifeng Biotech has completed pilot testing of products such as one-step polylactic acid (a bio-based degradable material), bio-succinic acid (a raw material for biodegradable PBS, and food and drug additives, etc.), and dextran (a raw material for bio-based iron supplements). Dextran products are being prepared for marketing (due to current limited market demand for dextrose anhydride, Ruifeng Biotech is marketing through pilot production line products.

Gelonghui FinanceMay 8 05:40